Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT02506231 Not yet recruiting - Clinical trials for Graft vs Host Disease

The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation Outcome

Start date: October 2015
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to assess the impact of folinic acid (FA) -rescue following methotrexate (MTX) graft-versus-host disease (GVHD) prophylaxis on regimen related toxicity and transplantation outcomes after allogeneic hematopoietic cell transplantation (alloHCT) in a double blind randomized controlled trial.

NCT ID: NCT02504801 Not yet recruiting - Lung Cancer Clinical Trials

Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD

Start date: July 2015
Phase: Phase 4
Study type: Interventional

To test the hypothesis that nebulized Pulmicort Respules could reduce post operation pulmonary complication incidence in primary lung cancer patients with COPD. Compare post-operation pulmonary complication incidence in two treatment arms among primary lung cancer patients with COPD required single lobectomy from 3days before operation to 7 days after operation.

NCT ID: NCT02504385 Not yet recruiting - Clinical trials for Developmental Coordination Disorder

The Effect of Virtual Reality on Motor Functioning and Participation Abilities Among Children With DCD

Start date: August 2015
Phase: N/A
Study type: Interventional

The subjet of this study is to explore the effect of using virtual reality environment at the clinic and at home (using Timocco) on the motor and participation abilities of children with DCD (Developmental Coordination Disorder). The study will examine the efficacy of using virtual reality gaming environment (Timocco) for treating children with DCD and the use of remote therapy, by shifting the focus of therapy from the clinic to the home environment, using the remote control system of Timocco for home practice.

NCT ID: NCT02500745 Not yet recruiting - Clinical trials for Thrombosis of Left Atrial Appendage

Left Atrial Volume Index and Left Atrial Appendage Flow Velocities

Start date: July 2015
Phase: N/A
Study type: Observational

After obtaining a consent, bed side cardiac ultrasonography will be performed for cases undergoing transesophageal echocardiography to evaluate the correlation between left atrium volume and left atrial appendage flow velocity which can predict the thrombosis risk.

NCT ID: NCT02498340 Not yet recruiting - Clinical trials for Glucose-6-Phosphate Dehydrogenase Deficiency

Diet Challenge in G6PD Deficient Egyptian Children: A One- Year Prospective Single Center Study With Genotype - Phenotype Correlation

Start date: December 2015
Phase: Phase 2/Phase 3
Study type: Interventional

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is prevalent and add a burden on families in Egypt and Middle East due to lifelong diet restriction, non-fava beans diet is main food for most families in the region and parents and doctors consider it as a prohibited food whatever the genetic or clinical phenotypes. The effective management is avoiding a spectrum of food and drugs causing oxidative stress. No data is available about the hazards of consumption of non-fava beans diet.

NCT ID: NCT02497820 Not yet recruiting - Clinical trials for Lynch Syndrome I (Site-specific Colonic Cancer)

Finding the Best Dose of Aspirin to Prevent Lynch Syndrome Cancers

CaPP3 Israel
Start date: September 2016
Phase: Phase 3
Study type: Interventional

A randomised double blind dose non-inferiority trial of a daily dose of 600mg versus 300mg versus 100mg of enteric coated aspirin as a cancer preventive in carriers of a germline pathological mismatch repair gene defect, Lynch Syndrome. Project 3 in the Cancer Prevention Programme (CaPP3).

NCT ID: NCT02495012 Not yet recruiting - Clinical trials for ST Segment Elevation Myocardial Infarction

Anfibatide Treatment in STEMI Patients

Start date: August 2015
Phase: Phase 2
Study type: Interventional

A Phase IIb clinical trial to investigate the safety and efficacy of antiplatelet thrombolysin injection for patients with ST Segment Elevation Myocardial Infarction (STEMI) before receiving PCI therapy, in order to provide evidence for Phase III design.

NCT ID: NCT02490735 Not yet recruiting - Clinical trials for Esophageal Squamous Cell Carcinoma

CIK in Treating Patients With Esophageal Cancer

Start date: August 2015
Phase: Phase 2
Study type: Interventional

Chemotherapy is the main treatment method for patients with Esophageal Cancer. However, Relapse remains the major cause of treatment failure.Biological therapies such as CIK stimulate the immune system and stop tumor cells from growing. A series of studies reported that cytokine-induced killer cells (CIK) have a broad anti-tumor spectrum. The investigators suppose that CIK will improve the prognosis. Combining chemotherapy with biological therapy may kill more tumor cells. In this study, the patients will be treated with CIK cells after chemotherapy. The purpose of this study is to evaluate the efficacy of CIK for Esophageal Cancer.

NCT ID: NCT02490605 Not yet recruiting - Clinical trials for Temporomandibular Joint Disorders

Effect of the Use of an Occlusal Plate on the Postural Alignment

Simone
Start date: July 2015
Phase: N/A
Study type: Interventional

The possible relationship between posture and instability of the masticatory muscles related to occlusion thus becomes the reason, the objective of this study. In this way, it will be possible to evaluate both postural alignment and postural balance in patients with signs and symptoms of temporomandibular joint disorder before and after the use of an occlusal plate. Our research will take place at the School of Odontology of the University of São Paulo in the clinics of the Occlusion and TMJ Services (SOA) and of the Envelhecer Sorrindo program, and the data will be collected in the Biophysics Laboratory of the School of Physical Education and Sports of the University of São Paulo. The population studies will be made up of 120 patients, 60 being part of the sample and the other 60 in the control group. All the patients in this study are over 20 years of age and are of both genders; the research criteria will be diagnosed by way of filling out the questionnaire of the RDC-TMD and complemented by way of diagnostic imaging via MRI of the temporomandibular joint. The study will be a clinical, randomized, controlled, prospective study and intervention. After the subjects' alignment is evaluated by way of photographs and their postural balance by way of a force platform, the group will the randomized; the sample group will receive an occlusal plate with criteria for occlusal stability (simultaneous, bilateral contacts with an absence of interference in the canine and anterior guides). The occlusal plate will be made from "Vacuum Form" acetate with a thickness of 1.5 mm; the simultaneous, bilateral, occlusal contacts and the canine and anterior guides will be obtained by way of autopolymerizable, acrylic resin with the mandible in a centric relationship. The occlusal plate will be controlled weekly. The control group will only receive orientation to do physiotherapeutic exercises seeking to correctly position the mandible in the resting position (maxillar teeth should be approximately 2 mm away from the mandibular teeth) while the tip of the tongue is positioned and accommodated on the roof of the mouth over the incisive papilla on the hard palate (without touching the teeth). The exercise will consist of repeatedly opening the mouth with the tongue cleaving to the roof of the mouth, 3 times per day, each period consisting of 3 sets with 15 repetitions. After 3 months, the two groups will be re-evaluated in terms of postural alignment and balance.

NCT ID: NCT02487134 Not yet recruiting - Clinical trials for Open Wound of Abdominal Wall With Complication

Trial of Routine Abdominal Wall Closure Versus Reinforcement With TIGR Matrix Onlay

PrevMesh
Start date: January 1, 2025
Phase: N/A
Study type: Interventional

Patients with at least two risk factors for incisional hernia undergoing abdominal surgery are eligible for inclusion. After accepting informed consent, patients are randomized into either closing the abdominal wall in a regular way with fascial sutures, or closing with fascial sutures together with placing a TIGR mesh as described. All patients are then monitored for signs of infection, wound rupture, incisional hernias, subcutaneous seroma as well as postoperative symptoms. All patients will be followed for at least 5 years. One year postoperatively, a computer scan is performed to detect asymptomatic incisional hernias.